title: Clinical effectiveness of decitabine in severe sickle cell disease.
authors.forename: Yogen
authors.initials: Y
authors.lastname: Saunthararajah
authors.forename: Robert
authors.initials: R
authors.lastname: Molokie
authors.forename: Santosh
authors.initials: S
authors.lastname: Saraf
authors.forename: Seema
authors.initials: S
authors.lastname: Sidhwani
authors.forename: Michel
authors.initials: M
authors.lastname: Gowhari
authors.forename: Steven
authors.initials: S
authors.lastname: Vara
authors.forename: Donald
authors.initials: D
authors.lastname: Lavelle
authors.forename: Joseph
authors.initials: J
authors.lastname: DeSimone
mesh_terms: D000328:Adult; D000755:Anemia, Sickle Cell / Q000188:drug therapy*; D001374:Azacitidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015254:DNA Modification Methylases / Q000037:antagonists & inhibitors; D000077209:Decitabine; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D004791:Enzyme Inhibitors; D000077209:Decitabine; D015254:DNA Modification Methylases; D001374:Azacitidine